文献速递乳房整形与再造显微修复重建

布比卡因与脂质体布比卡因用于单侧延期腹壁下深动脉穿支皮瓣游离重建术后疼痛管理的前瞻性随机对照比较

Prospective, Randomized, Controlled Comparison of Bupivacaine versus Liposomal Bupivacaine for Pain Management after Unilateral Delayed Deep Inferior Epigastric Perforator Free Flap Reconstruction.
PubMed 文献 · Plast Reconstr Surg · 2018-01-01

前瞻性随机对照盲法研究比较脂质体布比卡因腹横肌平面阻滞、布比卡因腹横肌平面阻滞与布比卡因疼痛泵在单侧延期腹壁下深动脉穿支皮瓣重建术后的镇痛效果,脂质体布比卡因腹横肌平面阻滞组术后静脉及总阿片类药物用量显著少于其他队列,且下床活动更早,总体住院费用组间相似。

要点

  • 脂质体布比卡因腹横肌平面阻滞组术后静脉及总阿片类药物用量(毫克及毫克/千克/天)显著少于其他队列。
  • 脂质体布比卡因腹横肌平面阻滞组下床活动时间早于其他队列。
  • 各组总体住院费用相似。

核心结论

  • 脂质体布比卡因腹横肌平面阻滞可显著减少单侧延期腹壁下深动脉穿支皮瓣重建术后静脉及总阿片类药物用量。
  • 未来需前瞻性研究脂质体布比卡因对即刻及双侧重建的影响。

研究设计与样本

  • 前瞻性、随机、对照、盲法研究,经机构审查委员会批准。
  • 纳入行单侧延期腹壁下深动脉穿支皮瓣重建的患者,随机分入脂质体布比卡因腹横肌平面阻滞组、布比卡因腹横肌平面阻滞组或布比卡因疼痛泵组。
  • 脂质体布比卡因组与布比卡因腹横肌平面阻滞组各8例,疼痛泵组5例;另纳入6例未接受任何干预的回顾性队列。
  • 回顾病历收集人口学资料、住院时长及术后麻醉药使用情况。

主要发现

  • 脂质体布比卡因腹横肌平面阻滞组术后静脉及总麻醉药用量(毫克及毫克/千克/天)显著少于所有其他队列。
  • 脂质体布比卡因腹横肌平面阻滞组下床活动时间早于其他队列。
  • 各组总体住院费用相似。

临床怎么用

  • 作者认为,使用脂质体布比卡因腹横肌平面阻滞可显著减少静脉及总麻醉药用量。
  • 原文未据此给出其他临床推荐。

局限性

  • 未来需前瞻性研究脂质体布比卡因对即刻及双侧重建的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Effective postsurgical analgesia is a critical aspect of patient recovery. The goal of this prospective, randomized, controlled, blinded study was to examine the effect that liposomal bupivacaine delivered by means of a transversus abdominis plane block has on pain control in women undergoing unilateral deep inferior epigastric perforator flap reconstruction. Institutional review board approval was granted for this prospective study. Patients were eligible if they were undergoing unilateral, delayed deep inferior epigastric perforator flap reconstruction. Patients were randomized to one of three groups: liposomal bupivacaine transversus abdominis plane block, or bupivacaine pain pump. Charts were reviewed for demographics, length of stay, and postoperative narcotic use. There were eight patients in the liposomal bupivacaine and bupivacaine transversus abdominis plane block groups and five patients in the pain pump group. A retrospective cohort of six patients who did not receive any intervention was included. Patients who received a liposomal bupivacaine transversus abdominis plane block used statistically significantly less intravenous and total postoperative narcotics in milligrams and milligrams per kilogram per day compared with all other cohorts. They were able to get out of bed at an earlier time point. Overall hospital costs were similar among the groups. This is the first study to investigate liposomal bupivacaine delivered as a transversus abdominis plane block in a prospective, randomized, blinded study in women undergoing unilateral, delayed, abdominally based autologous breast reconstruction. The authors were able to demonstrate a significant reduction in intravenous and total narcotic use when a liposomal bupivacaine transversus abdominis plane block was used. Future studies are needed to prospectively investigate the effect that liposomal bupivacaine would have on immediate and bilateral reconstructions.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Gatherwright J, Knackstedt RW, Ghaznavi AM, et al. Prospective, Randomized, Controlled Comparison of Bupivacaine versus Liposomal Bupivacaine for Pain Management after Unilateral Delayed Deep Inferior Epigastric Perforator Free Flap Reconstruction. Plast Reconstr Surg. 2018. PMID: 29750760. doi:10.1097/PRS.0000000000004360

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。